(Q42607851)

3 November 2017

title

The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis (English)

1 reference

3 November 2017

1 reference

Wells AU

1

1 reference

3 November 2017

Hansell DM

2

1 reference

3 November 2017

Rubens MB

3

1 reference

3 November 2017

Cullinan P

4

1 reference

3 November 2017

Black CM

5

1 reference

3 November 2017

du Bois RM

6

1 reference

3 November 2017

publication date

1 October 1993

1 reference

The American Review of Respiratory Disease

3 November 2017

published in

1 reference

3 November 2017

volume

148

1 reference

3 November 2017

issue

4 Pt 1

1 reference

3 November 2017

page(s)

1076-1082

1 reference

The prognosis of cryptogenic fibrosing alveolitis

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Cryptogenic fibrosing alveolitis: clinical features and their influence on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): Correlation of histology at biopsy with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

High resolution computed tomography as a predictor of lung histology in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Accuracy of the typical computed tomographic appearances of fibrosing alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Interstitial lung disease: current concepts of pathogenesis, staging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1076

10.1164/AJRCCM/148.4_PT_1.1076

21 January 2018

Identifiers

DOI

0 references

1 reference